UHS reported FY 2025 net revenues of USD 17.4 billion (+9.7%) and income from operations of USD 2.0 billion, with net income of USD 1.5 billion and net income attributable to shareholders of USD 1.5 billion (+30%). FY 2025 interest expense, net was USD 156.1 million (-16%), and the effective tax rate was 23.4% (vs. 22.4%). By segment, acute care net revenues were USD 9.9 billion (+11.0%) and income before income taxes was USD 1.0 billion (+25.0%). Behavioral health net revenues were USD 7.4 billion (+8.0%) and income before income taxes was USD 1.5 billion (+7.7%). UHS said FY 2025 net revenues benefited from same-facility growth and contributions from two newly constructed acute care hospitals: West Henderson Hospital in Las Vegas (opened Q4 2024) and Cedar Hill Regional Medical Center in Washington, D.C. (opened Q2 2025), while Cedar Hill generated a FY 2025 pre-tax loss of USD 49 million. The company also recorded a USD 93 million unrealized pre-tax gain tied to a minority investment in a healthcare generative AI company, and highlighted ongoing exposure to Medicaid supplemental payment programs (FY 2025 aggregate net benefit of USD 1.339 billion) alongside expected future reductions under the One Big Beautiful Bill Act beginning with the 2028 state fiscal years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Universal Health Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-071676), on February 25, 2026, and is solely responsible for the information contained therein.